Edgestream Partners, L.P. Amphastar Pharmaceuticals, Inc. Transaction History
Edgestream Partners, L.P.
- $3.48 Billion
- Q2 2025
A detailed history of Edgestream Partners, L.P. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Edgestream Partners, L.P. holds 37,112 shares of AMPH stock, worth $992,746. This represents 0.02% of its overall portfolio holdings.
Number of Shares
37,112Holding current value
$992,746% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.3MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$159 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$71.9 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$54.4 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$43.5 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$42.2 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.31B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...